Publishes | Webnewswire

MEDraysintell Publishes the 8th Edition of Its Nuclear Medicine Report & Directory

Sep 16, 2021 | Business

MEDraysintell releases the 8th. Edition of the Nuclear Medicine Report and Directory–2021, a set of three volumes aiming to provide a comprehensive and exhaustive review of the worldwide nuclear medicine landscape, through a detailed analysis of the existing marketed products and through the description and evaluation of the potential of radiopharmaceuticals under clinical or early-stage development and associated companies active in this field.

This new Edition-2021 provides in 3,100 pages a description of 870 products, together with a comprehensive profile of 340 companies active around the world in the radiopharmaceutical industry. The number of direct web links to bibliographical references was increased to 2,700.

– Nuclear Medicine (Part 1) – Marketed Radiopharmaceuticals

– Nuclear Medicine (Part 2) – Clinical Radiopharmaceuticals

– Nuclear Medicine (Part 3) – Early-Stage Radiopharmaceuticals

Additionally, a database containing all the clinal and early-stage radiopharmaceuticals described in the reports can also be provided to assist users in their research.

Detailed table of contents and sample pages are available upon request from Paul-Emmanuel Goethals at peg@medraysintell.com

MEDraysintell estimates that the global market for nuclear medicine reached just over US$ 5.6 billion in 2020, declining by almost 5% compared to 2019. The decline is a direct consequence of the COVID-19 pandemic, mainly seen during the first half of 2020. With the lockdown of most of the countries and major restriction on air travels, transport of radionuclides and radiopharmaceuticals became the main bottleneck to distribute those products to hospitals. However, the situation resumed to almost normal by end of year 2020.

During the past years, an increasing interest from private investors and conventional pharmaceutical industries for the nuclear medicine market continued to be observed, despite the pandemic, of course mainly in the therapeutic area. This led also to some major M&A activities. Over US$ 17 billion were invested in M&A transactions between 2014 and June 2021. Further to the M&A activities, nearly 50 radiopharmaceutical companies were able to raise a total of almost US$ 4 billion from January 2019 to June 2021, to finance their development. New opportunities for development, investments, mergers and acquisitions are just popping up.

Despite the fact that most congresses related to nuclear medicine went virtual in the past year due to the COVID-19 pandemic and the difficulties in pursuing in-person contacts, MEDraysintell was able to refine its data collection with more accurate information as new information became available. These three documents aim to support the reader in the development of their strategies in this industry.

About MEDraysintell

MEDraysintell is a team of international experts providing first-rate strategic intelligence in nuclear medicine, cyclotron, proton therapy and brachytherapy. We offer the most comprehensive set of reports and directories, with over 4,200 pages of unrivaled intelligence covering some of the most exciting healthcare technologies using radiation for diagnosis and treatment. We offer client-specific intelligence in the field of radiation healthcare, with the upmost knowledge leveraging our extended network of worldwide contacts.

We are proud to support numerous companies globally, helping them to better understand the markets, the competitive environment as well as the potential of merger and acquisitions (M&A) and technology development. We have repeated satisfied clients operating in the field of medical radiation, investment banks and institutional investors, large international consulting firms and university research laboratories.

MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. It combines a century of experience in radiation healthcare. www.medraysintell.com

MEDraysintell

Paul-Emmanuel Goethals

+32 491 080 968

www.medraysintell.com

Contact

Troy, OH Author Publishes Narrative

Aug 14, 2021 | Books, Business

Lights for Teresa, a new book by John Cobalt, has been released by RoseDog Books.

This book is based on the true story of a father who against all odds, found his only daughter who was taken by a maniacal abductor. It explains in detail the great legal, financial and emotional struggles as he works desperately to find her. He discovers the many faults in the justice system as well as inept and corrupt officials along the way. The story also explains how through the use of a variety of government agencies and social media that the extensive search ended in a successful recovery. The author tells the story from his firsthand experience of the events. This is a must read for anyone who is going through a custody battle and/or have had their children taken by a spouse.

Lights for Teresa is a 128-page paperback with a retail price of $13.00 (eBook $8.00). The ISBN is 978-1-6366-1033-7. It was published by RoseDog Books of Pittsburgh, Pennsylvania. For more information, or to request a review copy, please go to our virtual pressroom at https://dorrancepressroom.com/lights-for-teresa/ or our online bookstore at https://rosedogbookstore.com/lights-for-teresa-based-on-a-real-story-of-abduction-and-recovery/

Mars Hill, NC Author Publishes Children’s Book

Aug 10, 2021 | Books, Business

Betty Bluebird and Carl Cardinal, a new book written by Shannon McKerlie and inspired by Cassie McKerlie, has been released by RoseDog Books.

Betty and Carl are two birds in love. The only problem is that everyone else keeps telling them they shouldn’t be together because they’re different kinds of birds. Will they be able to overcome this obstacle and achieve their own happily ever after? This relatable and heartwarming story seeks to educate children about discrimination, particularly related to multi-racial relationships and families. Author Shannon McKerlie hopes to provide children with a concrete example of how prejudice can appear and arm them with the tools needed to overcome it through love and kindness.

About the Author
Shannon McKerlie has faced discrimination in her own life based on who she has loved, but she now lives with her beautiful wife and their sweet pets. She is a living example of how love can overcome adversity.

Betty Bluebird and Carl Cardinal is a 30-page hardcover with a retail price of $24.00 (eBook $19.00). The ISBN is 978-1-64957-851-8. It was published by RoseDog Books of Pittsburgh, Pennsylvania. For more information, or to request a review copy, please go to our virtual pressroom at www.dorrancepressroom.com or our online bookstore at https://rosedogbookstore.com/betty-bluebird-and-carl-cardinal/

R1D Music publishes their newest book to guide newcomers to the music industry

Jul 17, 2021 | Business

CA, USA, 16 July 2021, ZEXPRWIRE, The music industry is one of the most competitive industries out there. A person who is stepping into the music industry will have to face numerous frustrating challenges. Due to the same reason, establishing in the music industry as an artist can look like an impossible thing to do. R1D Music had a clear understanding of this as they worked with numerous upcoming artists who wanted to establish their presence in the competitive industry. That’s the main reason why they came up with the idea of publishing a comprehensive guide on how to establish itself in the music industry.

The new book by R1D Music is published under the title “How to Make It in The Music Biz: Crawl Before You Walk”. The authors have a plan to release multiple parts of the book. Part 1 is officially released as of now, and any interested artist can think about buying it. Then it is possible to get a better understanding of how to overcome the challenges that are associated with the music industry while trying to settle down.

This book is ideal for all the people who feel discouraged when trying to ensure a solid presence in the music industry. It provides beneficial information for such artists to follow. Any artist who follows this book will be able to get a better understanding of how to ensure survival in the music industry. It is more of an easy-to-follow step-by-step guide. Hence, no person would encounter challenges at the time of following this guide.

At the time of buying this book by R1D Music, it is important to keep in mind that this book will not provide overnight success. Instead, it will introduce the artists to a proven methodology, which can be followed to achieve success. The secret formula to success shared by this book is proven to deliver positive results to any artist. Hence, no artist entering into the music industry should think twice before getting hold of this book.it will help the artists to build their online music career and offline music career. Along with that, it is possible to earn a living out of music as well.

The book is currently available for sale and any artist can think of buying it. This would be one of the best investments that a beginner in the music industry can make.

BASF publishes fifth Palm Progress Report

Jul 16, 2021 | Business

From 2020, BASF sources all palm (kernel) oils exclusively from RSPO-certified sustainable sources
By 2025, the commitment to certified sourcing includes key palm oil and palm kernel oil-based intermediates
Portfolio for palm-based surfactants with RSPO certification continues to grow

BASF launched the fifth edition of its Palm Progress Report featuring figures for 2020. One of BASFs key renewable raw materials is palm kernel oil and its primary derivatives which are mainly used to produce ingredients for the cosmetics, detergent and cleaner industries, as well as in human nutrition.

In the past year, BASF has reached an important milestone on the road to sustainable palm oil. The company has committed to source palm (kernel) oils exclusively from RSPO-certified sustainable sources since then. In 2020, BASF purchased 227,213 metric tons of RSPO-certified sustainable palm (kernel) oil. This corresponds to 100 percent of the total volume purchased. In addition, BASF made further progress in developing transparent supply chains: almost 95 percent of the global oil palm footprint a total of 441,107 metric tons could be traced back to the oil mill.

BASF is now fully focused on the other part of its 2015 commitment: to also include the commitment of certified sourcing to those significant intermediates which are based on palm oil and palm kernel oil by 2025, e.g. fatty alcohols and fatty acids.

Portfolio for palm-based surfactants with RSPO certification continues to grow

The BASF Home Care, I&I and Industrial Formulators Europe business is expanding its portfolio of palm-based surfactants with RSPO certifications. It now offers around 150 surfactants certified according to the RSPO standard Mass Balance, in line with the companys efforts to work towards a sustainable future along the entire value chain. In addition, it is helping its European customers to meet consumer demand for environment-friendly products both in the detergents and cleaners industry and amongst users of industrial applications. As one of the first RSPO members, BASF is thus underlining its continued commitment to support the production of sustainable palm (kernel) oil in the future.

The Palm Progress Report and further information on BASFs commitment can be found here.

—-

About the Care Chemicals division at BASF

The BASF division Care Chemicals offers a broad range of ingredients for personal care, hygiene, home care, industrial & institutional cleaning, and technical applications. We are the global leading supplier for the cosmetics industry as well as the detergents and cleaners industry, and support our customers with innovative and sustainable products, solutions and concepts. The divisions highperformance product portfolio includes surfactants, emulsifiers, polymers, emollients, chelating agents, cosmetic active ingredients and UV filters. We have production and development sites in all regions and are expanding our presence in emerging markets. Further information is available online at www.care-chemicals.basf.com.

About BASF

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. More than 110,000 employees in the BASF Group contribute to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions. BASF generated sales of 59 billion in 2020. BASF shares are traded on the stock exchange in Frankfurt (BAS) and as American Depositary Receipts (BASFY) in the U.S. Further information at www.basf.com.